title: [Therapy of advanced prostate cancer].
abstract: The carcinoma of the prostate gland is a malignant tumour like the other. The locoregional carcinoma of the prostate gland is locally curatively treated with prostatovesiculectomy, percutaneous high-voltage therapy or interstitial radiotherapy. The disseminated diseases of the prostate gland is systemically palliatively treated. A survey is given of the forms of therapy for the advanced carcinoma of the prostate gland. The estrogen therapy has its justification still nowadays. With the preparation Turisteron (ethinylestradiol propansulphonate) of the VEB Jenapharm an oral depot estrogen is at our disposal, which has distinctly smaller side effects than diethylstilbestrol (DES).
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D002064:Buserelin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D045166:Estradiol Congeners / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009919:Orchiectomy; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000628:therapy*
chemical_list: D000726:Androgen Antagonists; D045166:Estradiol Congeners; D002064:Buserelin
vernacular_title: Zur Therapie des fortgeschrittenen Prostatakarzinoms.